Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

por Hojilla, C V, Mohammed, F F, Khokha, R
Publicado 2003

Angiogenesis inhibitors in clinical development; where are we now and where are we going?

por Eskens, F A L M
Publicado 2004

Total body irradiation and pneumonitis risk: a review of outcomes

por Carruthers, S A, Wallington, M M
Publicado 2004

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer

por Petrioli, R, Sabatino, M, Fiaschi, A I, Marsili, S, Pozzessere, D, Messinese, S, Correale, P, Civitelli, S, Tanzini, G, Tani, F, De Martino, A, Marzocca, G, Lorenzi, M, Giorgi, G, Francini, G
Publicado 2004

The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials

por Gottschalk, A R, Roach, M
Publicado 2004

The response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancer

por Barber, M D, McMillan, D C, Wallace, A M, Ross, J A, Preston, T, Fearon, K C H
Publicado 2004

Repair of radiation damage to DNA

por Willers, H, Dahm-Daphi, J, Powell, S N
Publicado 2004

Do preserved foods increase prostate cancer risk?

por Jian, L, Zhang, D H, Lee, A H, Binns, C W
Publicado 2004

Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case–control study in Florence

por Zappa, M, Visioli, C B, Ciatto, S, Iossa, A, Paci, E, Sasieni, P
Publicado 2004

The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions

por Terry, G, Ho, L, Londesborough, P, Cross, P, Lopes, A, Monaghan, J, Cuzick, J
Publicado 2004

Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer

por Jacot, W, Pujol, J-L, Boher, J-M, Lamy, P-J
Publicado 2004

Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene

por Berge, G, Øvrebø, S, Eilertsen, E, Haugen, A, Mollerup, S
Publicado 2004

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer

por Chan, S
Publicado 2004

Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy

por Moniaux, N, Andrianifahanana, M, Brand, R E, Batra, S K
Publicado 2004

Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it?

por Verburg, F A, Lips, C J M, Lentjes, E G W M, de Klerk, J M H
Publicado 2004

MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not

por Langers, A M J, Sier, C F M, Hawinkels, L J A C, Kubben, F J G M, van Duijn, W, van der Reijden, J J, Lamers, C B H W, Hommes, D W, Verspaget, H W
Publicado 2008

Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas

por Jones, S, Lambert, S, Williams, G T, Best, J M, Sampson, J R, Cheadle, J P
Publicado 2004

Role of osteopontin in tumour progression

por Rittling, S R, Chambers, A F
Publicado 2004

Reciprocal relationship between expression of hypoxia inducible factor 1α (HIF-1α) and the pro-apoptotic protein Bid in ex vivo colorectal cancer

por Seenath, M M, Roberts, D, Cawthorne, C, Saunders, M P, Armstrong, G R, O'Dwyer, S T, Stratford, I J, Dive, C, Renehan, A G
Publicado 2008

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

por Michelakis, E D, Webster, L, Mackey, J R
Publicado 2008